ESG
The daffodil, a symbol of hope for all people affected by cancer
With one in two Australians diagnosed with cancer by the age of 85, the Daffodil Day Appeal on 23 August is a cause that affects us all.
Research is vital to saving lives and finding less harsh cancer treatments. Money raised this Daffodil Day Appeal 23 August 2019 will help fund some of the brightest researchers in Australia who are dedicated to discovering the next cancer breakthroughs.
The daffodil is recognised internationally as the symbol of hope for all people affected by cancer. Cancer Council chose it as our emblem as it heralds the return of spring, pushing its way through the frozen earth after a long winter, representing new life, vitality and growth.
To Cancer Council, and those affected by cancer, the daffodil represents hope for a cancer free future.
The Daffodil Day Appeal is Cancer Council’s most iconic and much-loved fundraising campaign. It is a day for Australians to give hope to those affected by all cancers by donating to support a cancer free future.
This year the Daffodil Day Appeal aims to raise more than $4 million for life-saving cancer research. Raising awareness and money throughout the month of August, the Daffodil Day Appeal culminates in a public show of solidarity with volunteers collecting donations at sites across the country.
Help fund Australia’s brightest researchers as they work to uncover breakthrough cancer treatments to protect the ones you love.Donate now.
News & Trends - Pharmaceuticals
Medicines Australia and AusBiotech join Research Australia and Digital Health CRC in welcoming funding of national strategy for medical research and National One Stop Shop
Pharma News: Medicines Australia, AusBiotech, Research Australia and the Digital Health Cooperative Research Centre (DHCRC) applaud the funding announcement of […]
MoreNews & Trends - MedTech & Diagnostics
Health insurers clash with government on GUIs decision, prompting threat of premium hikes
MedTech & Diagnostics News: A warning of potential increases in health insurance premiums for 15 million Australians has been issued […]
MoreNews & Trends - MedTech & Diagnostics
Catheter ablation underused in atrial fibrillation despite proven efficacy
MedTech & Diagnostics News: A new study highlights that nearly half of all patients hospitalised for atrial fibrillation (AF) in […]
MoreNews & Trends - Biotechnology
How prepared are we for the next pandemic?
Biotech News: The Melbourne biotechnology community came together for a symposium hosted by BioMelbourne and mRNA Victoria, featuring specialists in […]
More